Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection

被引:12
|
作者
Bi, Sheng [1 ]
Yao, Xin [2 ]
Huang, Cheng [1 ,3 ]
Zheng, Xia [4 ]
Xuan, Tianming [5 ]
Sheng, Jifang [1 ]
Xu, Kaijin [1 ]
Zheng, Beiwen [1 ,7 ]
Yang, Qing [6 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China
[3] Lihuili Hosp, Ningbo Med Ctr, Dept Resp Med, Ningbo, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiovasc, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou, Zhejiang, Peoples R China
[7] Chinese Acad Inspect & Quarantine, Inst Anim Quarantine, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Carbapenem-resistance; KPC-2-producing Klebsiella pneumoniae; Tigecycline; Meropenem; Antagonistic effect; GENTAMICIN; POLYMYXIN; EFFICACY; THERAPY;
D O I
10.1007/s15010-019-01274-w
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
IntroductionA woman infected by carbapenem-resistant Klebsiella pneumoniae is reported in this study.Case reportTigecycline and meropenem combination was used, and indeed, in vitro checkerboard synergy test confirmed the antagonism between the two antibiotics. Thus, meropenem was ceased and single high-dose tigecycline was successful against the infection. Subsequent experiments showed that the isolates of the KPC-2-producing K. pneumoniae ST11 clone caused the infection.ConclusionTherefore, tigecycline and meropenem combination should be used with caution.
引用
收藏
页码:497 / 500
页数:4
相关论文
共 50 条
  • [1] Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection
    Sheng Bi
    Xin Yao
    Cheng Huang
    Xia Zheng
    Tianming Xuan
    Jifang Sheng
    Kaijin Xu
    Beiwen Zheng
    Qing Yang
    Infection, 2019, 47 : 497 - 500
  • [2] Emergence of KPC-producing Klebsiella pneumoniae in Italy
    Fontana C.
    Favaro M.
    Sarmati L.
    Natoli S.
    Altieri A.
    Bossa M.C.
    Minelli S.
    Leonardis F.
    Favalli C.
    BMC Research Notes, 3 (1)
  • [3] Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae
    Kulengowski, Brandon
    Campion, Jeffrey J.
    Feola, David J.
    Burgess, David S.
    JOURNAL OF ANTIBIOTICS, 2017, 70 (09) : 974 - 978
  • [4] Pharmacokinetics of the Meropenem Component of Meropenem-Vaborbactam in the Treatment of KPC-Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient
    Hanretty, Alexandra M.
    Kaur, Ishminder
    Evangelista, Alan T.
    Moore, Wayne S., II
    Enache, Adela
    Chopra, Arun
    Cies, Jeffrey J.
    PHARMACOTHERAPY, 2018, 38 (12): : e87 - e91
  • [5] First report of KPC-producing Klebsiella pneumoniae in Croatia
    Bedenic, Branka
    Mazzariol, Annarita
    Plecko, Vanda
    Bosnjak, Zrinka
    Barl, Petra
    Vranes, Jasmina
    Cornaglia, Giuseppe
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (04) : 237 - 239
  • [6] A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae
    Yasmin, Mohamad
    Marshall, Steven H.
    Chen, Liang
    Rhoads, Daniel D.
    Jacobs, Michael R.
    Rojas, Laura J.
    Perez, Federico
    Hujer, Andrea M.
    Hujer, Kristine M.
    van Duin, David
    Fowler, Vance
    Chambers, Henry F.
    Kreiswirth, Barry N.
    Bonomo, Robert A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024,
  • [7] Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient
    Gaibani, Paolo
    Bussini, Linda
    Amadesi, Stefano
    Bartoletti, Michele
    Bovo, Federica
    Lazzarotto, Tiziana
    Viale, Pierluigi
    Ambretti, Simone
    MICROORGANISMS, 2022, 10 (04)
  • [8] Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient
    Piedra-Carrasco, Nuria
    Miguel, Lucia
    Fabrega, Anna
    Vinado, Belen
    Campany, David
    Mir, Alba
    Laura Fox, Maria
    Almirante, Benito
    Larrosa, Nieves
    Ruiz-Camps, Isabel
    Jose Gonzalez-Lopez, Juan
    MICROBIAL DRUG RESISTANCE, 2018, 24 (02) : 199 - 202
  • [9] Synergy Testing by E-Test and Microdilution Checkerboard for Fosfomycin Combined with Tigecycline against KPC-Producing Klebsiella pneumoniae
    Huang, Lei
    Wang, Mingying
    Sun, Liying
    CLINICAL LABORATORY, 2019, 65 (12) : 2369 - 2375
  • [10] Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
    Ni, Wentao
    Wei, Chuanqi
    Zhou, Chufei
    Zhao, Jin
    Liang, Beibei
    Cui, Junchang
    Wang, Rui
    Liu, Youning
    FRONTIERS IN MICROBIOLOGY, 2016, 7